Kentuckiana Cancer Institute, PLLC

Louisville, Kentucky 40202

0 studies enrolling now · 9 studies all time

What they study most

Breast Cancer, Colorectal Carcinoma, Leukemia, Lung Cancer, Nausea and Vomiting, Non Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Nonresectable Adrenocortical Carcinoma, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes

Studies at this site

• APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer — Completed
• Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer — Completed
• Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer — Completed
• Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer — Status unconfirmed
• Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC) — Completed
• Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment — Completed
• A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer — Completed
• PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer — Stopped early
• Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma — Completed